Chong Kun Dang Holdings Files Large Shareholding Report (No Specific Details)
-
Only the report form was submitted; specific figures such as number of shares held, changes, and reasons were not filled in. -
No separate shareholder return policy or financial changes were identified, so it is considered a neutral issue.
KOSPI Filing Information
- Filing: Report on Large Shareholding (General)
- Company: Chong Kun Dang Pharmaceutical (185750)
- Submission: Lee Jang-han
- Receipt: 02-03-2026